EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Anticancer Potential of Antimicrobial Peptides: Mechanisms, Clinical Application, Challenges, and Future Prospects

Qiang Zhang, Shengjun Li, Zhen Wang, Xu Qiu, Xingmiao Yang, Shuai Li, Zheng Gong, Bin Wang, Bei Zhang iD, Li Zhang iD

Drug Development Research · 2026

DOI: 10.1002/ddr.70383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, 2026. Verfasst von Qiang Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Immunology, School of Basic Medicine, Qingdao University, Qingdao, Shandong Province, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Antimicrobial Peptides, Neoplasms, Antimicrobial Cationic Peptides. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Shandong Province, China, The China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy‐induced adverse effects and drug resistance remain major obstacles limiting the therapeutic efficacy of cancer treatment, underscoring an urgent need for novel anticancer agents. Among promising candidate molecules, antimicrobial peptides (AMPs) exhibit considerable therapeutic potential owing to their unique mechanisms of action, potent anticancer activity, minimal off‐target toxicity, and low propensity to induce drug resistance. In this review, we summarize recent advances in the anticancer properties of AMPs, with a focus on their effects on both cancer cells and immune cells across diverse cancer types, clinical applications, as well as current challenges and future prospects. This review highlights the promise of AMPs as highly effective anticancer candidates for combination cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsAntimicrobial PeptidesNeoplasmsAntimicrobial Cationic PeptidesHumansAnimals

Stichwörter der Autor:innen

antimicrobial peptidescancer therapyclinical applicationdrug resistanceimmune regulation

Substanzen

Antineoplastic AgentsAntimicrobial PeptidesAntimicrobial Cationic Peptides

Autor:innen und Institutionen

  • The Department of Immunology, School of Basic Medicine, Qingdao University, Qingdao, Shandong Province, China.
  • Clinical Laboratory, Qingdao Women and Children's Hospital, Qingdao, Shandong Province, China.
  • Department of Basic Medicine, Xiangnan University, Chenzhou, Hunan Province, China.
  • Sino-Cellbiomed Institutes of Medical Cell & Pharmaceutical Proteins Qingdao University, Qingdao, Shandong Province, China.
  • The Department of Pathogenic Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong Province, China.
  • School of Health Management, Qingdao Hengxing University of Science and Technology, Qingdao, Shandong Province, China.

ORCID-Profile: Bei Zhang, Li Zhang

Förderung

  • Natural Science Foundation of Shandong Province, China
  • The China Postdoctoral Science Foundation

Zitieren

APA

Zhang, Q., Li, S., Wang, Z., Qiu, X., Yang, X., Li, S., Gong, Z., Wang, B., Zhang, B., & Zhang, L. (2026). Anticancer Potential of Antimicrobial Peptides: Mechanisms, Clinical Application, Challenges, and Future Prospects. Drug Development Research. https://doi.org/10.1002/ddr.70383

Vancouver

Zhang Q, Li S, Wang Z, Qiu X, Yang X, Li S, et al. Anticancer Potential of Antimicrobial Peptides: Mechanisms, Clinical Application, Challenges, and Future Prospects. Drug Development Research. 2026. doi:10.1002/ddr.70383

BibTeX
@article{Zhang2026,
  author = {Zhang, Qiang and Li, Shengjun and Wang, Zhen and Qiu, Xu and Yang, Xingmiao and Li, Shuai and Gong, Zheng and Wang, Bin and Zhang, Bei and Zhang, Li},
  title = {Anticancer Potential of Antimicrobial Peptides: Mechanisms, Clinical Application, Challenges, and Future Prospects},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70383}
}
Kostenlos starten →